These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32453205)

  • 1. Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria.
    Demirci E; Akyel R; Caner B; Alan-Selçuk N; Güven-Meşe Ş; Ocak M; Kabasakal L
    Nucl Med Commun; 2020 Aug; 41(8):759-767. PubMed ID: 32453205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interobserver and intraobserver agreement in PET/CT with [
    Guerra-Gómez M; Rodríguez-Pajuelo A; Brero-Sánchez L; Cuenca-Cuenca JI; Álvarez-Pérez RM; Freire-Macías JM; Jiménez-Hoyuela García JM
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(5):500047. PubMed ID: 39121988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interreader agreement in evaluation of 68Ga-PSMA PET/CT at the time of initial staging: comparison of the three evaluation criteria in the pretreatment risk groups.
    Karahan Şen NP; Aksu A; Bozkurt O; Tuna EB; Çapa Kaya G
    Nucl Med Commun; 2022 Jan; 43(1):86-91. PubMed ID: 34559761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 68Ga-PSMA-I&T-PET/CT interobserver and intraobserver agreement for prostate cancer: a lesion based and subregional comparison study among observers with different levels of experience.
    Soyluoglu S; Korkmaz U; Ozdemir B; Ustun F; Durmus-Altun G
    Nucl Med Commun; 2021 Oct; 42(10):1122-1129. PubMed ID: 34001829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraobserver and interobserver agreement for the interpretation of 68Ga-prostate-specific membrane antigen-I&T positron emission tomography/computed tomography imaging.
    Gültekin A; Yaylalı O; Şengöz T; Yüksel D; Şahin B
    Nucl Med Commun; 2019 Dec; 40(12):1250-1255. PubMed ID: 31584465
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Fendler WP; Calais J; Allen-Auerbach M; Bluemel C; Eberhardt N; Emmett L; Gupta P; Hartenbach M; Hope TA; Okamoto S; Pfob CH; Pöppel TD; Rischpler C; Schwarzenböck S; Stebner V; Unterrainer M; Zacho HD; Maurer T; Gratzke C; Crispin A; Czernin J; Herrmann K; Eiber M
    J Nucl Med; 2017 Oct; 58(10):1617-1623. PubMed ID: 28408531
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Klingenberg S; Jochumsen MR; Ulhøi BP; Fredsøe J; Sørensen KD; Borre M; Bouchelouche K
    J Nucl Med; 2021 Feb; 62(2):214-220. PubMed ID: 32444374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Mainta IC; Neroladaki A; Wolf NB; Benamran D; Boudabbous S; Zilli T; Garibotto V
    J Nucl Med; 2024 Sep; 65(9):1376-1382. PubMed ID: 39117453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on
    Werner RA; Bundschuh RA; Bundschuh L; Javadi MS; Leal JP; Higuchi T; Pienta KJ; Buck AK; Pomper MG; Gorin MA; Lapa C; Rowe SP
    J Nucl Med; 2018 Dec; 59(12):1857-1864. PubMed ID: 30190304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of [68Ga]Ga-PSMA-11 PET/CT in initial staging of patients with prostate cancer and importance of intraprostatic SUVmax values.
    Rogic I; Golubic AT; Zuvic M; Smitran T; Jukic N; Gamulin M; Kastelan Z; Huic D
    Nucl Med Rev Cent East Eur; 2024; 27(0):6-12. PubMed ID: 38680016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interobserver variability, detection rate, and lesion patterns of
    Miksch J; Bottke D; Krohn T; Thamm R; Bartkowiak D; Solbach C; Bolenz C; Beer M; Wiegel T; Beer AJ; Prasad V
    Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2339-2347. PubMed ID: 32157427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interobserver agreement of [
    Derwael C; Lavergne O; Lovinfosse P; Nechifor V; Salvé M; Waltregny D; Hustinx R; Withofs N
    EJNMMI Res; 2020 Feb; 10(1):15. PubMed ID: 32112230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability and practicability of PSMA-RADS 1.0 for structured reporting of PSMA-PET/CT scans in prostate cancer patients.
    Grawe F; Blom F; Winkelmann M; Burgard C; Schmid-Tannwald C; Unterrainer LM; Sheikh GT; Pfitzinger PL; Kazmierczak P; Cyran CC; Ricke J; Stief CG; Bartenstein P; Ruebenthaler J; Fabritius MP; Geyer T
    Eur Radiol; 2024 Feb; 34(2):1157-1166. PubMed ID: 37624414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How accurate is
    Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Vinsensia M; Chyoke PL; Hadaschik B; Holland-Letz T; Moltz J; Kopka K; Rauscher I; Mier W; Schwaiger M; Haberkorn U; Mauer T; Kratochwil C; Eiber M; Giesel FL
    J Nucl Med; 2017 Dec; 58(12):1949-1955. PubMed ID: 28637799
    [No Abstract]   [Full Text] [Related]  

  • 17.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of metastatic disease on
    Yaxley JW; Raveenthiran S; Nouhaud FX; Samaratunga H; Yaxley WJ; Coughlin G; Yaxley AJ; Gianduzzo T; Kua B; McEwan L; Wong D
    BJU Int; 2019 Sep; 124(3):401-407. PubMed ID: 31141284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer GTV delineation with biparametric MRI and
    Hearn N; Blazak J; Vivian P; Vignarajah D; Cahill K; Atwell D; Lagopoulos J; Min M
    Br J Radiol; 2021 Mar; 94(1119):20201174. PubMed ID: 33507812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ga68-PSMA PET for lymph node staging in intermediate and high-risk prostate cancer patients undergoing robotic assisted radical prostatectomy.
    Spena G; Moretti TB; Dávila FS; Dos Anjos G; Khan I; Calace FP; Aveta A; Pandolfo SD; Tufano A; Izzo A; Farias A; Perdonà S; Maes K
    Minerva Urol Nephrol; 2024 Aug; 76(4):467-473. PubMed ID: 39051893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.